MedImmune Development Product
MedImmune Development Product. Means the MEDI-4736 antibody binding to Programmed DEATH-Ligand1 (PD-L1), also known as cluster of differentiation 274 (CD274) or B7 homolog1 (B7-H1)
All Definitions
Found in
Advaxis, Inc. contract
